文章摘要

文章信息/Info

Title:: -

作者:: 乔志卿综述; 何奔审校; 上海交通大学医学院附属仁济医院心内科，上海 200127

Author(s):: -

关键词:: 药物洗脱支架; 支架内再狭窄; 分型; 预测因素

Keywords:: -

分类号:: R541.4

DOI:: -

文献标识码:: A

摘要:: 药物洗脱支架（DES）有效地降低了再狭窄（RS）发生率，扩大了冠脉介入治疗的领域，然而，随着介入治疗的病变越来越复杂，病例越来越多，其本身的再狭窄问题也变得令人瞩目，如何处理DES后的支架内再狭窄，已经成为心脏病学面临的新挑战。本文就DES的RS类型特点、出现RS的原因及预测因素、RS的治疗策略作一综述。

Abstract:: -

参考文献/References

［1］陈丹，吕安林，苑媛，等. 药物涂层支架研究进展［J］. 心脏杂志, 2006, 18(5):591-594.

［2］ Stone GW, Ellis SG, Cannon L, et al. Comparison of a polymerbased paclitaxeleluting stent with a bare metal stent in patients with complex coronary artery disease：a randomized controlled trial［J］. JAMA, 2005, 294（10）：1215-1223.

［3］ Colombo A, Moses JW, Morice MC, et al. Randomized study to evaluate sirolimuseluting stents implanted at coronary bifurcation lesions［J］. Circulation, 2004, 109（10）:1244-1249.

［4］ Chieffo A, Stankovic G, Bonizzoni E, et al. Early and midterm results of drugeluting stent implantation in unprotected left main［J］.Circulation, 2005, 111（6）:791-795.

［5］ Stone GW, Ellis SG, Cox DA, et al. A polymerbased, paclitaxeleluting stent in patients with coronary artery disease［J］. N Engl J Med, 2004, 350（3）:221-231.

［6］ Iakovou I, Schmidt T, Ge L, et al. Angiographic patterns of restenosis after paclitaxeleluting stent implantation［J］. J Am Coll Cardiol, 2005, 45（5）：805-806.

［7］ Kastrati A, Dibra A, Mehilli J, et al. Predictive factors of restenosis after coronary implantation of sirolimus or paclitaxeleluting stents［J］. Circulation, 2006, 113（19）:2293-2300.

［8］ Lee CW, Park DK, Lee BK, et al. Predictors of restenosis after placement of drugeluting Stents in one or more coronary arteries［J］. Am J Cardiol, 2006, 97（4）:506-511.

［9］ Hong MK, Lee CW, Kim YH, et al. Intravascular ultrasound predictors and their cutoff values for angiographic restenosis after sirolimuseluting stent implantation［J］. JACC, 2006, 47（4）:189A.

［10］Mauri L, O’Malley AJ, Popma JJ, et al. Comparison of thrombosis and restenosis risk from stent length of sirolimuseluting stents versus bare metal stents［J］. Am J Cardiol, 2005, 95（10）:1140-1145.

［11］Hong SJ, Kim MH, Ahn TH, et al. Multiple predictors of coronary restenosis after drugeluting stent implantation in patients with diabetes［J］. Heart, 2006, 92(8):1119-1124.

［12］Lemos PA, Hoye A, Goedhart D, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimuseluting stent implantation in complex patients:an evaluation from the rapamycineluting stent evaluated at rotterdam cardiology hospital (RESEARCH) study［J］. Circulation, 2004, 109（11）:1366-1370.

［13］Berenguer A, Mainar V, Bordes P, et al. Incidence and predictors of restenosis after sirolimuseluting stent implantation in highrisk patients［J］. Am Heart J, 2005, 150(3):536-542.

［14］Takebayashi H, Kobayashi Y, Mintz GS, et al. Intravascular ultrasound assessment of lesions with target vessel failure after sirolimuseluting stent implantation［J］. Am J Cardiol, 2005, 95（4）:498-502.

［15］Moussa ID, Moses JW, Kuntz RE, et al. The fate of patients with clinical recurrence after sirolimuseluting stent implantation (a twoyear followup analysis from the SIRIUS trial)［J］. Am J Cardiol, 2006, 97（11）:1582-1584.

［16］Lemos PA, van Mieghem CA, Arampatzis CA, et al. Postsirolimuseluting stent restenosis treated with repeat percutaneous intervention late angiographic and clinical outcomes［J］. Circulation, 2004, 109（21）:2500-2502.

我们的网站为什么显示成这样？

药物洗脱支架植入后的支架内再狭窄的研究进展(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

文章信息/Info

参考文献/References

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics